| 508438 |
THERANOSTICS |
The “ART” of Epigenetics in Melanoma: From histone “Alterations, to Resistance and Therapies” |
2020-01-01 |
10.7150/thno.36218 |
Strub Thomas, Ballotti Robert, Bertolotto Corine |
| 508437 |
THERANOSTICS |
Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology |
2020-01-01 |
10.7150/thno.40298 |
Yang Jun, Shi Zhuyan, Liu Ruiyuan, Wu Yanyue, Zhang Xin |
| 508436 |
THERANOSTICS |
Dissolving Microneedles with Spatiotemporally controlled pulsatile release Nanosystem for Synergistic Chemo-photothermal Therapy of Melanoma |
2020-01-01 |
10.7150/thno.44194 |
Qin Wanbing, Quan Guilan, Sun Ying, Chen Minglong, Yang Peipei, Feng Disang, Wen Ting, Hu Xinyu, Pan Xin, Wu Chuanbin |
| 508435 |
CLINICAL MEDICINE : JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON |
Response |
2020-01-01 |
10.7861/clinmedicine.20-1-120a |
Induruwa Isuru, Holland Negin, Gregory Rosalind, Khadjooi Kayvan |
| 508434 |
대한영상의학회지 |
Erratum: Application of Three Dimensional Printed Models in Congenital Heart Surgery: Surgeon's Perspective |
2020-01-01 |
10.3348/jksr.2020.81.3.754 |
Kim, Hyungtae, Choo, Ki Seok, Sung, Si Chan, Choi, Kwang Ho, Lee, Hyoung Doo, Ko, Hoon, Byun, Joung-Hee, Cho, Byung Hee |
| 508433 |
INDIAN JOURNAL OF OPHTHALMOLOGY |
Comments on: Using Brückner's test for gross keratometry screening |
2020-01-01 |
10.4103/ijo.ijo_1240_19 |
Kothari Mihir, Jahan Shairin, Solanki Meghna |
| 508432 |
INDIAN JOURNAL OF OPHTHALMOLOGY |
Retinopathy of prematurity: Maharashtra state model |
2020-01-01 |
10.4103/ijo.ijo_1867_19 |
Kulkarni Sucheta, Kadam Sandeep, Patil Archana, Gilbert Clare |
| 508431 |
INDIAN JOURNAL OF OPHTHALMOLOGY |
An editorial perspective on the infamous COVID-19 studies retracted by Lancet and NEJM |
2020-01-01 |
10.4103/ijo.ijo_1853_20 |
Sengupta Sabyasachi |
| 508430 |
INDIAN JOURNAL OF OPHTHALMOLOGY |
Commentary: Eye banking during COVID-19 pandemic |
2020-01-01 |
10.4103/ijo.ijo_3163_20 |
Prajna NVenkatesh, Radhakrishnan Naveen |
| 508429 |
ONCOIMMUNOLOGY |
Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome |
2020-01-01 |
10.1080/2162402x.2020.1760705 |
Brunekreeft Kim L., Paijens Sterre T., Wouters Maartje C.A., Komdeur Fenne L., Eggink Florine A., Lubbers Joyce M., Workel Hagma H., Van Der Slikke Elisabeth C., Pröpper Noor E.J., Leffers Ninke, Adam Julien, Pijper Harry, Plat Annechien, Kol Arjan, Nijman Hans W., De Bruyn Marco |
